Smartlab Europe

Veeva Launches First iPad CRM/CLM Cloud Application

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.
- Advertisement -

Veeva Systems, the leader in cloud-based business solutions for the global life sciences industry, recently launched iRep, the industry’s first iPad CRM/CLM cloud application for life sciences sales representatives. Veeva’s iRep has made life easier for life sciences sales representatives, who now can access FaceTime (News – Alert), to instantly connect face-to-face with other members of the commercial team during a meeting with a physician. “It’s hard to imagine that pharma technology could get much more exciting than it already is right now, but it has. Apple’s (News – Alert) upgrades to the industry’s most popular new device ratchet its significance up and with iRep, the possibilities seem endless for life sciences companies. We’re really excited to see our customers leverage cool new features like FaceTime,” said Brian Longo, senior director of product development at Veeva, in a statement.

With Veeva’s iRep, a sales rep can also access live video chat and plug-and-play projection. Moreover, the app also ensures fast rendering of HTML 5 content thanks to an updated Safari browser. Like Veeva CRM, iRep can be updated in minutes and changes can be made as needed so reps are always up to date and armed with compliant information. A sales rep can also leverage the iPad’s presentation of multimedia content while aligning sales and marketing strategies.  “It’s like bringing an expert along for every sales call…truly amazing,” added Longo.

iRep is yet another innovative product from Veeva, which recently expanded its partnership with Salesforce.com (News – Alert) to accelerate the delivery of the Veeva CRM applications to the global pharmaceutical and biotechnology industry. Veeva uses Salesforce.com’s enterprise cloud computing platform, Force.com, to strengthen its position in the Pharma CRM industry. Both partners have teamed on offering integrated multi-channel CRM applications delivered via the cloud to the global pharmaceutical and biotech industries. With the partnership, Veeva is now salesforce.com’s premier Independent Software Vendor (ISV) partner for sales force automation in the pharmaceutical and biotechnology segment.

Latest stories

Related stories

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »